AVXL | Anavex Life Sciences’ Low Stock Price Makes It A Target

AVXL Stock, Anavex Life Sciences Corp., AnavexThis week, we begin with a penny stock alert issued on a biopharmaceutical, development stage company we like (a lot) — Anavex Life Sciences Corp. (AVXL). The company has a lead drug candidate, ANAVEX 2-73, which scored much better Phase I results than many of the high-profile failures in the Alzheimer’s disease space. Considering that the upside potential for AVXL ...

Continue Reading →